Abstract
This commentary discusses the early licensing and deployment of a COVID-19 vaccine and how accomplishing this goal could compromise ethical principles that guide clinical research.
| Original language | English |
|---|---|
| Journal | Annals of Internal Medicine |
| Volume | 174 |
| Issue number | 2 |
| Pages (from-to) | 258-260 |
| Number of pages | 3 |
| ISSN | 0003-4819 |
| DOIs | |
| Publication status | Published - 1 Feb 2021 |
Keywords
- COVID-19 Vaccines
- COVID-19/epidemiology
- Drug Industry/ethics
- Ethics, Research
- Humans
- Pandemics
- Randomized Controlled Trials as Topic/ethics
- Research Design
- SARS-CoV-2
- United States
- United States Food and Drug Administration
Fingerprint
Dive into the research topics of 'Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS